Check Credit Score
Check Credit Score
HomeNewsIndia

India COVID-19 cases will cross 10 lakh-mark this week: Rahul Gandhi

Rahul Gandhi criticised the government asking if India was in a "good position" in the battle against the virus.

July 14, 2020 / 12:57 PM IST

Congress leader Rahul Gandhi on July 14 said the total number of coronavirus cases in the country could cross the 10 lakh-mark this week. He had on Monday questioned the Centre's claims on battling COVID-19, asking if India was at a "good position" in the battle against the virus.

He has been critical of the government's handling of the situation. "This week, the figure of 10,00,000 will be crossed in our country,"  Gandhi said in a tweet in Hindi.

Gandhi also tagged a news report quoting the WHO chief who had said that if concrete steps were not taken, the coronavirus situation in the world would turn from bad to worse.

The World Health Organisation (WHO) chief on Monday slammed some government leaders for eroding public trust by sending mixed messages on coronavirus and warned that their failure to stop their countries' spiralling outbreaks meant there would be no return to normal for the foreseeable future.

With 28,498 fresh cases recorded in a day, India's COVID-19 tally sprinted past nine lakh on Tuesday, just three days after it crossed the eight lakh-mark, according to the Union health ministry data.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The total coronavirus caseload in the country surged to 9,06,752 and the death toll mounted to 23,727 with 553 people succumbing to the disease in 24 hours, the data updated at 8 am on Tuesday showed.

Follow our full coverage of the coronavirus pandemic here.

PTI
first published: Jul 14, 2020 11:45 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347